Iovance Biotherapeutics, Inc. IOVA Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$79.05M-9.9% | -$71.9M+21.2% | -$91.25M+18.3% | -$111.66M+3.9% | -$116.16M-47.9% | ||
| $2.82M-24.2% | $3.72M+24.7% | $2.99M-12.2% | $3.4M+32.3% | $2.57M-21.5% | ||
| $11.27M-4.6% | $11.82M-0.7% | $11.9M-20.4% | $14.94M-34.8% | $22.92M-26.0% | ||
| -$72.07M-37.1% | -$52.57M+33.2% | -$78.7M-16.7% | -$67.45M+35.0% | -$103.69M-41.5% | ||
| $6.61M-29.1% | $9.32M-14.1% | $10.84M+45.3% | $7.46M+20.1% | $6.21M+49.0% | ||
| $11.39M+1,370% | $775K-95.4% | $17.01M+22.9% | $13.84M-12.8% | $15.87M— | ||
| $94.34M+67.9% | $56.17M-36.2% | $88.06M+566% | $13.23M-90.8% | $143.32M+6,107% | ||
| $33.44M+574% | $4.96M-80.7% | $25.69M— | —— | $56M+215% | ||
| -$78.68M-27.1% | -$61.89M+30.9% | -$89.55M-19.5% | -$74.91M+31.8% | -$109.91M-41.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Iovance Biotherapeutics, Inc. generate?
- Iovance Biotherapeutics, Inc. (IOVA) generated -$270.8M in operating cash flow over the trailing twelve months.
- What is Iovance Biotherapeutics, Inc.'s free cash flow?
- After $34.2M of capital expenditures, Iovance Biotherapeutics, Inc.'s free cash flow was -$305.0M over the trailing twelve months, up 12.2% year over year.
- Where does Iovance Biotherapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Iovance Biotherapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
